Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or Nelfinavir

Brian J. Kirby, Ann C. Collier, Evan D. Kharasch, Dale Whittington, Kenneth E. Thummel and Jashvant D. Unadkat
Drug Metabolism and Disposition June 2011, 39 (6) 1070-1078; DOI: https://doi.org/10.1124/dmd.110.037523
Brian J. Kirby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann C. Collier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan D. Kharasch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale Whittington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth E. Thummel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jashvant D. Unadkat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 39 no. 6 1070-1078
DOI 
https://doi.org/10.1124/dmd.110.037523
PubMed 
21406602

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 3, 2010
  • Accepted March 9, 2011
  • Published online May 16, 2011.

Article Versions

  • Earlier version (March 15, 2011 - 10:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Brian J. Kirby,
  2. Ann C. Collier,
  3. Evan D. Kharasch,
  4. Dale Whittington,
  5. Kenneth E. Thummel and
  6. Jashvant D. Unadkat
  1. Departments of Pharmaceutics (B.J.K., D.W., K.E.T., J.D.U.) and Medicine (A.C.C.), University of Washington, Seattle Washington; and Department of Anesthesiology, Washington University, St. Louis, Missouri (E.D.K.)
  1. Address correspondence to:
    Dr. Jashvant D. Unadkat, Department of Pharmaceutics, School of Pharmacy, Box 357610, University of Washington, Seattle WA 98195-7610. E-mail: jash{at}u.washington.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 201752513
Sep 201712311
Oct 20173348
Nov 20173288
Dec 20171217
Jan 20180163
Feb 20182187
Mar 20181167
Apr 201811667
May 201809412
Jun 20180896
Jul 201844910
Aug 201813512
Sep 201834513
Oct 201828112
Nov 201848412
Dec 201859177
Jan 20196034
Feb 20194733
Mar 20192844
Apr 20192447
May 20191455
Jun 20191006
Jul 20191111
Aug 20192312
Oct 20191146
Nov 20191747
Dec 20191163
Jan 20202742
Feb 20201835
Mar 20203326
May 20202333
Jun 2020921
Jul 20201933
Aug 20201132
Sep 20203166
Oct 2020241212
Nov 20202253
Dec 20201624
Jan 202127206
Feb 202124174
Mar 202124104
Apr 20212185
May 202123125
Jun 20211172
Jul 202124514
Aug 202113136
Sep 20212043
Oct 20212542
Nov 202118410
Dec 20212744
Jan 20222795
Feb 20221687
Mar 20222741
Apr 202223138
May 2022521015
Jun 20222521
Jul 2022241413
Aug 20222573
Sep 202226146
Oct 202215173
Nov 20221628
Dec 20224375
Jan 20233092

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 39 (6)
Drug Metabolism and Disposition
Vol. 39, Issue 6
1 Jun 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or Nelfinavir
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or Nelfinavir

Brian J. Kirby, Ann C. Collier, Evan D. Kharasch, Dale Whittington, Kenneth E. Thummel and Jashvant D. Unadkat
Drug Metabolism and Disposition June 1, 2011, 39 (6) 1070-1078; DOI: https://doi.org/10.1124/dmd.110.037523

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Complex Drug Interactions of HIV Protease Inhibitors 1: Inactivation, Induction, and Inhibition of Cytochrome P450 3A by Ritonavir or Nelfinavir

Brian J. Kirby, Ann C. Collier, Evan D. Kharasch, Dale Whittington, Kenneth E. Thummel and Jashvant D. Unadkat
Drug Metabolism and Disposition June 1, 2011, 39 (6) 1070-1078; DOI: https://doi.org/10.1124/dmd.110.037523
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of payload-containing catabolites of ADCs
  • PK Interactions of Licorice with Cytochrome P450s
  • Biotransformation of Trastuzumab and Pertuzumab
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics